Includes pharmaceutical, herbal and street drugs by four classes and combinations, with molecular structure, links to additional information, and, for brand name drugs, indications and approval dates.
FDA Drug Approval News
- 1.7.2022 Quviviq for insomnia
- 11.12.2021 Dhivy for Parkinson's
- 11.5.2021 Eprontia for seizures and migraine
- 10.15.2021 ZIMHI for opioid overdose
- 10.4.2021 Zercapli for MDD and OCD
- 8.30.2021 Invega Hafyera for Schizophrenia
- 8.27.2021 Loreev XR for Anxiety Disorders
- 6.7.2021 Aduhelm for Alzheimer's